{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T04:08:59Z","timestamp":1788926939279,"version":"build-2803163510"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,6,17]],"date-time":"2023-06-17T00:00:00Z","timestamp":1686960000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,17]],"date-time":"2023-06-17T00:00:00Z","timestamp":1686960000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007343","name":"Universit\u00e0 degli Studi di Brescia","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007343","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The therapeutic advance in hereditary transthyretin amyloidosis (ATTRv amyloidosis) requires quantitative biomarkers of nerve involvement in order to foster early diagnosis and monitor therapy response. We aimed at quantitatively assessing Magnetic Resonance Neurography (MRN) and Diffusion Tensor Imaging (DTI) properties of the sciatic nerve in subjects with ATTRv-amyloidosis-polyneuropathy (ATTRv-PN) and pre-symptomatic carriers (ATTRv-C). Twenty subjects with pathogenic variants of the TTR gene (mean age 62.20\u2009\u00b1\u200912.04\u00a0years), 13 ATTRv-PN, and 7 ATTRv-C were evaluated and compared with 20 healthy subjects (mean age 60.1\u2009\u00b1\u20098.27\u00a0years). MRN and DTI sequences were performed at the right thigh from the gluteal region to the popliteal fossa. Cross-sectional-area (CSA), normalized signal intensity (NSI), and DTI metrics, including fractional anisotropy (FA), mean (MD), axial (AD), and radial diffusivity (RD) of the right sciatic nerve were measured. Increased CSA, NSI, RD, and reduced FA of sciatic nerve differentiated ATTRv-PN from ATTRv-C and healthy subjects at all levels (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01). NSI differentiated ATTRv-C from controls at all levels (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05), RD at proximal and mid-thigh (1.04\u2009\u00b1\u20090.1 vs 0.86\u2009\u00b1\u20090.11 <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01), FA at mid-thigh (0.51\u2009\u00b1\u20090.02 vs 0.58\u2009\u00b1\u20090.04 <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01). According to receiver operating characteristic (ROC) curve analysis, cutoff values differentiating ATTRv-C from controls (and therefore identifying subclinical sciatic involvement) were defined for FA, RD, and NSI. Significant correlations between MRI measures, clinical involvement and neurophysiology were found. In conclusion, the combination of quantitative MRN and DTI of the sciatic nerve can reliably differentiate ATTRv-PN, ATTRv-C, and healthy controls. More important, MRN and DTI were able to non-invasively identify early subclinical microstructural changes in pre-symptomatic carriers, thus representing a potential tool for early diagnosis and disease monitoring.<\/jats:p>","DOI":"10.1007\/s00415-023-11813-z","type":"journal-article","created":{"date-parts":[[2023,6,17]],"date-time":"2023-06-17T07:01:31Z","timestamp":1686985291000},"page":"4827-4840","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Magnetic resonance neurography and diffusion tensor imaging of the sciatic nerve in hereditary transthyretin amyloidosis polyneuropathy"],"prefix":"10.1007","volume":"270","author":[{"given":"Roberto","family":"Gasparotti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Salvalaggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Corbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Agazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Cacciavillani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Lozza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Fenu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grazia","family":"De Vigili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Tagliapietra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Maria","family":"Fabrizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Pareyson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Obici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Briani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,17]]},"reference":[{"issue":"7","key":"11813_CR1","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41582-019-0210-4","volume":"15","author":"D Adams","year":"2019","unstructured":"Adams D, Koike H, Slama M, Coelho T (2019) Hereditary transthyretin amyloidosis: a model of medical progress for a fatal disease. Nat Rev Neurol 15(7):387\u2013404. https:\/\/doi.org\/10.1038\/s41582-019-0210-4","journal-title":"Nat Rev Neurol"},{"issue":"21","key":"11813_CR2","doi-asserted-by":"publisher","first-page":"e1999","DOI":"10.1212\/WNL.0000000000006543","volume":"91","author":"T Coelho","year":"2018","unstructured":"Coelho T et al (2018) Natural history and survival in stage 1 Val30Met transthyretin familial amyloid polyneuropathy. Neurology 91(21):e1999\u2013e2009","journal-title":"Neurology"},{"issue":"4","key":"11813_CR3","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1007\/s00415-017-8708-4","volume":"265","author":"V Plante-Bordeneuve","year":"2018","unstructured":"Plante-Bordeneuve V (2018) Transthyretin familial amyloid polyneuropathy: an update. J Neurol 265(4):976\u2013983. https:\/\/doi.org\/10.1007\/s00415-017-8708-4","journal-title":"J Neurol"},{"issue":"1","key":"11813_CR4","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1185\/03007995.2012.754348","volume":"29","author":"T Coelho","year":"2013","unstructured":"Coelho T, Maurer MS, Suhr OB (2013) THAOS\u2014the transthyretin amyloidosis outcomes survey: initial report on clinical manifestations in patients with hereditary and wild-type transthyretin amyloidosis. Curr Med Res Opin 29(1):63\u201376. https:\/\/doi.org\/10.1185\/03007995.2012.754348","journal-title":"Curr Med Res Opin"},{"issue":"2","key":"11813_CR5","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s10072-020-04889-2","volume":"43","author":"F Manganelli","year":"2022","unstructured":"Manganelli F, Fabrizi GM, Luigetti M, Mandich P, Mazzeo A, Pareyson D (2022) Hereditary transthyretin amyloidosis overview. Neurol Sci 43(2):595\u2013604. https:\/\/doi.org\/10.1007\/s10072-020-04889-2","journal-title":"Neurol Sci"},{"issue":"1","key":"11813_CR6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1716153","volume":"379","author":"D Adams","year":"2018","unstructured":"Adams D, Gonzalez-Duarte A, O\u2019Riordan WD et al (2018) Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis. N Engl J Med 379(1):11\u201321. https:\/\/doi.org\/10.1056\/NEJMoa1716153","journal-title":"N Engl J Med"},{"issue":"1","key":"11813_CR7","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1056\/NEJMoa1716793","volume":"379","author":"MD Benson","year":"2018","unstructured":"Benson MD, Waddington-Cruz M, Berk JL et al (2018) Inotersen treatment for patients with hereditary transthyretin amyloidosis. N Engl J Med 379(1):22\u201331. https:\/\/doi.org\/10.1056\/NEJMoa1716793","journal-title":"N Engl J Med"},{"issue":"8","key":"11813_CR8","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1212\/WNL.0b013e3182661eb1","volume":"79","author":"T Coelho","year":"2012","unstructured":"Coelho T, Maia LF, Martins da Silva A et al (2012) Tafamidis for transthyretin familial amyloid polyneuropathy: a randomized, controlled trial. Neurology 79(8):785\u2013792. https:\/\/doi.org\/10.1212\/WNL.0b013e3182661eb1","journal-title":"Neurology"},{"issue":"5","key":"11813_CR9","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1002\/acn3.51049","volume":"7","author":"J Kollmer","year":"2020","unstructured":"Kollmer J, Hegenbart U, Kimmich C et al (2020) Magnetization transfer ratio quantifies polyneuropathy in hereditary transthyretin amyloidosis. Ann Clin Transl Neurol 7(5):799\u2013807. https:\/\/doi.org\/10.1002\/acn3.51049","journal-title":"Ann Clin Transl Neurol"},{"issue":"Pt 3","key":"11813_CR10","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1093\/brain\/awu344","volume":"138","author":"J Kollmer","year":"2015","unstructured":"Kollmer J, Hund E, Hornung B et al (2015) In vivo detection of nerve injury in familial amyloid polyneuropathy by magnetic resonance neurography. Brain 138(Pt 3):549\u2013562. https:\/\/doi.org\/10.1093\/brain\/awu344","journal-title":"Brain"},{"issue":"5","key":"11813_CR11","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1212\/WNL.0000000000004178","volume":"89","author":"J Kollmer","year":"2017","unstructured":"Kollmer J, Sahm F, Hegenbart U et al (2017) Sural nerve injury in familial amyloid polyneuropathy: MR neurography vs clinicopathologic tools. Neurology 89(5):475\u2013484. https:\/\/doi.org\/10.1212\/WNL.0000000000004178","journal-title":"Neurology"},{"issue":"11","key":"11813_CR12","doi-asserted-by":"publisher","first-page":"7865","DOI":"10.1007\/s00330-022-08748-w","volume":"32","author":"J Hodel","year":"2022","unstructured":"Hodel J, Benadjaoud S, Benadjaoud MA, Lefaucheur JP, Plant\u00e9-Bordeneuve V (2022) 3-T MR neurography of lumbo-sacral plexus in hereditary transthyretin-related amyloidosis with polyneuropathy. Eur Radiol 32(11):7865\u20137871. https:\/\/doi.org\/10.1007\/s00330-022-08748-w","journal-title":"Eur Radiol"},{"issue":"4","key":"11813_CR13","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1007\/s13311-021-01166-8","volume":"18","author":"J Kollmer","year":"2021","unstructured":"Kollmer J, Bendszus M (2021) Magnetic resonance neurography: improved diagnosis of peripheral neuropathies. Neurotherapeutics 18(4):2368\u20132383","journal-title":"Neurotherapeutics"},{"issue":"8","key":"11813_CR14","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1097\/RLI.0000000000000156","volume":"50","author":"MO Breckwoldt","year":"2015","unstructured":"Breckwoldt MO, Stock C, Xia A et al (2015) Diffusion tensor imaging adds diagnostic accuracy in magnetic resonance neurography. Invest Radiol 50(8):498\u2013504. https:\/\/doi.org\/10.1097\/RLI.0000000000000156","journal-title":"Invest Radiol"},{"key":"11813_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0130833","author":"A Heckel","year":"2015","unstructured":"Heckel A, Weiler M, Xia A et al (2015) Peripheral nerve diffusion tensor imaging: assessment of axon and myelin sheath integrity. PLoS One. https:\/\/doi.org\/10.1371\/journal.pone.0130833","journal-title":"PLoS One"},{"issue":"5","key":"11813_CR16","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1002\/jmri.25876","volume":"47","author":"T Jeon","year":"2018","unstructured":"Jeon T, Fung MM, Koch KM, Tan ET, Sneag DB (2018) Peripheral nerve diffusion tensor imaging: overview, pitfalls, and future directions. J Magn Reson Imaging 47(5):1171\u20131189. https:\/\/doi.org\/10.1002\/jmri.25876","journal-title":"J Magn Reson Imaging"},{"issue":"4","key":"11813_CR17","doi-asserted-by":"publisher","first-page":"398","DOI":"10.21037\/qims.2017.08.01","volume":"7","author":"T Martin Noguerol","year":"2017","unstructured":"Martin Noguerol T, Barousse R, Socolovsky M, Luna A (2017) Quantitative magnetic resonance (MR) neurography for evaluation of peripheral nerves and plexus injuries. Quant Imaging Med Surg 7(4):398\u2013421. https:\/\/doi.org\/10.21037\/qims.2017.08.01","journal-title":"Quant Imaging Med Surg"},{"issue":"5","key":"11813_CR18","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1007\/s00330-017-5134-z","volume":"28","author":"M Kronlage","year":"2018","unstructured":"Kronlage M, Schwehr V, Schwarz D et al (2018) Peripheral nerve diffusion tensor imaging (DTI): normal values and demographic determinants in a cohort of 60 healthy individuals. Eur Radiol 28(5):1801\u20131808. https:\/\/doi.org\/10.1007\/s00330-017-5134-z","journal-title":"Eur Radiol"},{"issue":"2","key":"11813_CR19","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1097\/RLI.0b013e3182775267","volume":"48","author":"R Gasparotti","year":"2013","unstructured":"Gasparotti R, Lodoli G, Meoded A, Carletti F, Garozzo D, Ferraresi S (2013) Feasibility of diffusion tensor tractography of brachial plexus injuries at 1.5 T. Invest Radiol 48(2):104\u2013112. https:\/\/doi.org\/10.1097\/RLI.0b013e3182775267","journal-title":"Invest Radiol"},{"key":"11813_CR20","doi-asserted-by":"publisher","first-page":"109110","DOI":"10.1016\/j.ejrad.2020.109110","volume":"129","author":"AS Gersing","year":"2020","unstructured":"Gersing AS, Cervantes B, Knebel C et al (2020) Diffusion tensor imaging and tractography for preoperative assessment of benign peripheral nerve sheath tumors. Eur J Radiol 129:109110. https:\/\/doi.org\/10.1016\/j.ejrad.2020.109110","journal-title":"Eur J Radiol"},{"issue":"4","key":"11813_CR21","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1002\/jmri.25964","volume":"48","author":"W Haakma","year":"2018","unstructured":"Haakma W, Hendrikse J, Uhrenholt L et al (2018) Multicenter reproducibility study of diffusion MRI and fiber tractography of the lumbosacral nerves. J Magn Reson Imaging 48(4):951\u2013963. https:\/\/doi.org\/10.1002\/jmri.25964","journal-title":"J Magn Reson Imaging"},{"key":"11813_CR22","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.mri.2021.08.003","volume":"83","author":"N Lemos","year":"2021","unstructured":"Lemos N, Melo HJF, Sermer C et al (2021) Lumbosacral plexus MR tractography: a novel diagnostic tool for extraspinal sciatica and pudendal neuralgia? Magn Reson Imaging 83:107\u2013113. https:\/\/doi.org\/10.1016\/j.mri.2021.08.003","journal-title":"Magn Reson Imaging"},{"key":"11813_CR23","doi-asserted-by":"publisher","first-page":"e57","DOI":"10.1016\/j.wneu.2019.01.154","volume":"126","author":"KN Liang","year":"2019","unstructured":"Liang KN, Feng PY, Feng XR, Cheng H (2019) Diffusion tensor imaging and fiber tractography reveal significant microstructural changes of cervical nerve roots in patients with cervical spondylotic radiculopathy. World Neurosurg 126:e57\u2013e64. https:\/\/doi.org\/10.1016\/j.wneu.2019.01.154","journal-title":"World Neurosurg"},{"issue":"8","key":"11813_CR24","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1177\/0284185120951965","volume":"62","author":"SY Park","year":"2021","unstructured":"Park SY, Koh SH, Lee IJ, Lee K, Lee Y (2021) Determination of optimum pixel size and slice thickness for tractography and ulnar nerve diffusion tensor imaging at the cubital tunnel using 3T MRI. Acta Radiol 62(8):1063\u20131071. https:\/\/doi.org\/10.1177\/0284185120951965","journal-title":"Acta Radiol"},{"issue":"1","key":"11813_CR25","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s13018-017-0690-0","volume":"12","author":"Y Wako","year":"2017","unstructured":"Wako Y, Nakamura J, Eguchi Y et al (2017) Diffusion tensor imaging and tractography of the sciatic and femoral nerves in healthy volunteers at 3T. J Orthop Surg Res 12(1):184. https:\/\/doi.org\/10.1186\/s13018-017-0690-0","journal-title":"J Orthop Surg Res"},{"issue":"1","key":"11813_CR26","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s00415-020-10127-8","volume":"268","author":"A Salvalaggio","year":"2021","unstructured":"Salvalaggio A, Coraci D, Cacciavillani M et al (2021) Nerve ultrasound in hereditary transthyretin amyloidosis: red flags and possible progression biomarkers. J Neurol 268(1):189\u2013198. https:\/\/doi.org\/10.1007\/s00415-020-10127-8","journal-title":"J Neurol"},{"issue":"6","key":"11813_CR27","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1007\/s10072-020-05033-w","volume":"42","author":"A Salvalaggio","year":"2021","unstructured":"Salvalaggio A, Coraci D, Cacciavillani M, Padua L, Briani C (2021) Nerve ultrasonography features in hereditary transthyretin amyloidosis with V30M mutation and polyneuropathy. Neurol Sci 42(6):2547\u20132548. https:\/\/doi.org\/10.1007\/s10072-020-05033-w","journal-title":"Neurol Sci"},{"issue":"4","key":"11813_CR28","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1007\/s00415-021-10754-9","volume":"269","author":"A Salvalaggio","year":"2022","unstructured":"Salvalaggio A, Coraci D, Obici L et al (2022) Progressive brachial plexus enlargement in hereditary transthyretin amyloidosis. J Neurol 269(4):1905\u20131912. https:\/\/doi.org\/10.1007\/s00415-021-10754-9","journal-title":"J Neurol"},{"issue":"Suppl 1","key":"11813_CR29","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000052074","volume":"41","author":"V Bril","year":"1999","unstructured":"Bril V (1999) NIS-LL: the primary measurement scale for clinical trial endpoints in diabetic peripheral neuropathy. Eur Neurol 41(Suppl 1):8\u201313. https:\/\/doi.org\/10.1159\/000052074","journal-title":"Eur Neurol"},{"issue":"2","key":"11813_CR30","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1212\/01.WNL.0000149522.32823.EA","volume":"64","author":"JD England","year":"2005","unstructured":"England JD, Gronseth GS, Franklin G et al (2005) Distal symmetric polyneuropathy: a definition for clinical research: report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology 64(2):199\u2013207. https:\/\/doi.org\/10.1212\/01.WNL.0000149522.32823.EA","journal-title":"Neurology"},{"issue":"12","key":"11813_CR31","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/S1474-4422(11)70246-0","volume":"10","author":"V Plant\u00e9-Bordeneuve","year":"2011","unstructured":"Plant\u00e9-Bordeneuve V, Said G (2011) Familial amyloid polyneuropathy. Lancet Neurol 10(12):1086\u20131097. https:\/\/doi.org\/10.1016\/S1474-4422(11)70246-0","journal-title":"Lancet Neurol"},{"issue":"4","key":"11813_CR32","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1007\/s13311-021-01154-y","volume":"18","author":"L Obici","year":"2021","unstructured":"Obici L, Mussinelli R (2021) Current and emerging therapies for hereditary transthyretin amyloidosis: strides towards a brighter future. Neurotherapeutics 18(4):2286\u20132302. https:\/\/doi.org\/10.1007\/s13311-021-01154-y","journal-title":"Neurotherapeutics"},{"issue":"1","key":"11813_CR33","doi-asserted-by":"publisher","first-page":"E18","DOI":"10.1002\/mus.25766","volume":"57","author":"L Padua","year":"2018","unstructured":"Padua L, Coraci D, Lucchetta M et al (2018) Different nerve ultrasound patterns in charcot-marie-tooth types and hereditary neuropathy with liability to pressure palsies. Muscle Nerve 57(1):E18\u2013E23. https:\/\/doi.org\/10.1002\/mus.25766","journal-title":"Muscle Nerve"},{"issue":"6","key":"11813_CR34","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1002\/mus.21431","volume":"40","author":"CM Zaidman","year":"2009","unstructured":"Zaidman CM, Al-Lozi M, Pestronk A (2009) Peripheral nerve size in normals and patients with polyneuropathy: an ultrasound study. Muscle Nerve 40(6):960\u2013966. https:\/\/doi.org\/10.1002\/mus.21431","journal-title":"Muscle Nerve"},{"issue":"4","key":"11813_CR35","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1002\/ana.410250405","volume":"25","author":"N Hanyu","year":"1989","unstructured":"Hanyu N, Ikeda S, Nakadai A, Yanagisawa N, Powell HC (1989) Peripheral nerve pathological findings in familial amyloid polyneuropathy: a correlative study of proximal sciatic nerve and sural nerve lesions. Ann Neurol 25(4):340\u2013350. https:\/\/doi.org\/10.1002\/ana.410250405","journal-title":"Ann Neurol"},{"issue":"7","key":"11813_CR36","doi-asserted-by":"publisher","first-page":"e625","DOI":"10.1212\/WNL.0000000000006002","volume":"91","author":"J Kollmer","year":"2018","unstructured":"Kollmer J, Weiler M, Purrucker J et al (2018) MR neurography biomarkers to characterize peripheral neuropathy in AL amyloidosis. Neurology 91(7):e625\u2013e634. https:\/\/doi.org\/10.1212\/WNL.0000000000006002","journal-title":"Neurology"},{"issue":"6","key":"11813_CR37","doi-asserted-by":"publisher","first-page":"E78","DOI":"10.1002\/mus.25691","volume":"56","author":"M Vaeggemose","year":"2017","unstructured":"Vaeggemose M, Vaeth S, Pham M et al (2017) Magnetic resonance neurography and diffusion tensor imaging of the peripheral nerves in patients with Charcot-Marie-Tooth Type 1A. Muscle Nerve 56(6):E78\u2013E84. https:\/\/doi.org\/10.1002\/mus.25691","journal-title":"Muscle Nerve"},{"issue":"2","key":"11813_CR38","doi-asserted-by":"publisher","first-page":"107439","DOI":"10.1016\/j.jdiacomp.2019.107439","volume":"34","author":"M Vaeggemose","year":"2020","unstructured":"Vaeggemose M, Haakma W, Pham M et al (2020) Diffusion tensor imaging MR neurography detects polyneuropathy in type 2 diabetes. J Diabetes Complications 34(2):107439. https:\/\/doi.org\/10.1016\/j.jdiacomp.2019.107439","journal-title":"J Diabetes Complications"},{"issue":"6","key":"11813_CR39","doi-asserted-by":"publisher","first-page":"3241","DOI":"10.1007\/s00330-018-5958-1","volume":"29","author":"HS Kim","year":"2019","unstructured":"Kim HS, Yoon YC, Choi BO, Jin W, Cha JG, Kim JH (2019) Diffusion tensor imaging of the sciatic nerve in Charcot-Marie-Tooth disease type I patients: a prospective case-control study. Eur Radiol 29(6):3241\u20133252. https:\/\/doi.org\/10.1007\/s00330-018-5958-1","journal-title":"Eur Radiol"},{"key":"11813_CR40","doi-asserted-by":"publisher","first-page":"110007","DOI":"10.1016\/j.ejrad.2021.110007","volume":"145","author":"X Xia","year":"2021","unstructured":"Xia X, Dai L, Zhou H et al (2021) Assessment of peripheral neuropathy in type 2 diabetes by diffusion tensor imaging: a case-control study. Eur J Radiol 145:110007. https:\/\/doi.org\/10.1016\/j.ejrad.2021.110007","journal-title":"Eur J Radiol"},{"issue":"5","key":"11813_CR41","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1136\/jnnp-2016-315262","volume":"88","author":"A Cortese","year":"2017","unstructured":"Cortese A, Vegezzi E, Lozza A et al (2017) Diagnostic challenges in hereditary transthyretin amyloidosis with polyneuropathy: avoiding misdiagnosis of a treatable hereditary neuropathy. J Neurol Neurosurg Psychiatry 88(5):457\u2013458. https:\/\/doi.org\/10.1136\/jnnp-2016-315262","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"11813_CR42","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1002\/jmri.27354","volume":"53","author":"PL Cheah","year":"2021","unstructured":"Cheah PL, Krisnan T, Wong JHD et al (2021) Microstructural Integrity of peripheral nerves in charcot-marie-tooth disease: an MRI evaluation study. J Magn Reson Imaging 53(2):437\u2013444. https:\/\/doi.org\/10.1002\/jmri.27354","journal-title":"J Magn Reson Imaging"},{"issue":"1","key":"11813_CR43","doi-asserted-by":"publisher","first-page":"395","DOI":"10.21037\/qims-21-126","volume":"12","author":"X Wang","year":"2022","unstructured":"Wang X, Luo L, Xing J et al (2022) Assessment of peripheral neuropathy in type 2 diabetes by diffusion tensor imaging. Quant Imaging Med Surg 12(1):395\u2013405. https:\/\/doi.org\/10.21037\/qims-21-126","journal-title":"Quant Imaging Med Surg"},{"issue":"8","key":"11813_CR44","doi-asserted-by":"publisher","first-page":"3523","DOI":"10.1007\/s00330-016-4698-3","volume":"27","author":"C Wu","year":"2017","unstructured":"Wu C, Wang G, Zhao Y et al (2017) Assessment of tibial and common peroneal nerves in diabetic peripheral neuropathy by diffusion tensor imaging: a case control study. Eur Radiol 27(8):3523\u20133531. https:\/\/doi.org\/10.1007\/s00330-016-4698-3","journal-title":"Eur Radiol"},{"issue":"10","key":"11813_CR45","doi-asserted-by":"publisher","first-page":"e590","DOI":"10.1016\/j.ejrad.2013.05.011","volume":"82","author":"R Guggenberger","year":"2013","unstructured":"Guggenberger R, Nanz D, Bussmann L et al (2013) Diffusion tensor imaging of the median nerve at 3.0 T using different MR scanners: agreement of FA and ADC measurements. Eur J Radiol 82(10):e590\u2013e596. https:\/\/doi.org\/10.1016\/j.ejrad.2013.05.011","journal-title":"Eur J Radiol"},{"issue":"1","key":"11813_CR46","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.clinph.2017.10.028","volume":"129","author":"BF D\u00e9card","year":"2018","unstructured":"D\u00e9card BF, Pham M, Grimm A (2018) Ultrasound and MRI of nerves for monitoring disease activity and treatment effects in chronic dysimmune neuropathies\u2014current concepts and future directions. Clin Neurophysiol 129(1):155\u2013167. https:\/\/doi.org\/10.1016\/j.clinph.2017.10.028","journal-title":"Clin Neurophysiol"},{"issue":"6","key":"11813_CR47","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1016\/s0002-9440(10)63050-7","volume":"159","author":"MM Sousa","year":"2001","unstructured":"Sousa MM, Cardoso I, Fernandes R, Guimar\u00e3es A, Saraiva MJ (2001) Deposition of transthyretin in early stages of familial amyloidotic polyneuropathy: evidence for toxicity of nonfibrillar aggregates. Am J Pathol 159(6):1993\u20132000. https:\/\/doi.org\/10.1016\/s0002-9440(10)63050-7","journal-title":"Am J Pathol"},{"issue":"21","key":"11813_CR48","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1212\/WNL.0000000000003362","volume":"87","author":"H Koike","year":"2016","unstructured":"Koike H, Ikeda S, Takahashi M et al (2016) Schwann cell and endothelial cell damage in transthyretin familial amyloid polyneuropathy. Neurology 87(21):2220\u20132229. https:\/\/doi.org\/10.1212\/WNL.0000000000003362","journal-title":"Neurology"},{"issue":"2","key":"11813_CR49","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1007\/BF00294378","volume":"79","author":"C Sommer","year":"1989","unstructured":"Sommer C, Schr\u00f6der JM (1989) Amyloid neuropathy: immunocytochemical localization of intra- and extracellular immunoglobulin light chains. Acta Neuropathol 79(2):190\u2013199. https:\/\/doi.org\/10.1007\/BF00294378","journal-title":"Acta Neuropathol"},{"issue":"1","key":"11813_CR50","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3390\/biomedicines7010011","volume":"7","author":"H Koike","year":"2019","unstructured":"Koike H, Katsuno M (2019) Ultrastructure in transthyretin amyloidosis: from pathophysiology to therapeutic insights. Biomedicines 7(1):11. https:\/\/doi.org\/10.3390\/biomedicines7010011","journal-title":"Biomedicines"},{"issue":"1","key":"11813_CR51","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1080\/13506129.2018.1556156","volume":"26","author":"I Concei\u00e7\u00e3o","year":"2019","unstructured":"Concei\u00e7\u00e3o I, Damy T, Romero M et al (2019) Early diagnosis of ATTR amyloidosis through targeted follow-up of identified carriers of TTR gene mutations. Amyloid 26(1):3\u20139. https:\/\/doi.org\/10.1080\/13506129.2018.1556156","journal-title":"Amyloid"},{"issue":"1","key":"11813_CR52","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1186\/s13023-020-01633-z","volume":"15","author":"M Grandis","year":"2020","unstructured":"Grandis M, Obici L, Luigetti M et al (2020) Recommendations for pre-symptomatic genetic testing for hereditary transthyretin amyloidosis in the era of effective therapy: a multicenter Italian consensus. Orphanet J Rare Dis 15(1):348. https:\/\/doi.org\/10.1186\/s13023-020-01633-z","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"11813_CR53","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1080\/13506129.2020.1794807","volume":"27","author":"M Russo","year":"2020","unstructured":"Russo M, Obici L, Bartolomei I et al (2020) ATTRv amyloidosis Italian Registry: clinical and epidemiological data. Amyloid 27(4):259\u2013265. https:\/\/doi.org\/10.1080\/13506129.2020.1794807","journal-title":"Amyloid"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-023-11813-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-023-11813-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-023-11813-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T04:03:29Z","timestamp":1695182609000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-023-11813-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,17]]},"references-count":53,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["11813"],"URL":"https:\/\/doi.org\/10.1007\/s00415-023-11813-z","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,17]]},"assertion":[{"value":"28 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}